Terms: = Endocrine gland cancer AND STIL, SIL, 6491, ENSG00000123473, Q15468 AND Treatment
23 results:
1. The clinical efficacy of Apatinib plus Ba Zhen granules in the treatment of advanced unresectable differentiated thyroid cancer and their influence on immune factors.
Bai Y; Jin J; Liu Y; Zhang B; Li J
Pak J Pharm Sci; 2023 May; 36(3(Special)):935-939. PubMed ID: 37587701
[TBL] [Abstract] [Full Text] [Related]
2. Pathological findings and long-term prognosis in Korean BRCA1/2 mutation carriers undergoing risk-reducing salpingo-oophorectomy.
Kang OJ; Lee SW; Kim JH; Park JY; Suh DS; Kim DY; Kim JH; Kim YM; Kim YT
Int J Gynecol Cancer; 2023 Nov; 33(11):1743-1749. PubMed ID: 37541685
[TBL] [Abstract] [Full Text] [Related]
3. Establishment and validation of a LC-MS/MS method for the determination of anlotinib in human plasma: Application to therapeutic drug monitoring.
Yu M; Liang Z; Xiong L; Liu F; Cheng L; Jia C; Qi X; Sun F
Biomed Chromatogr; 2022 Dec; 36(12):e5501. PubMed ID: 36082703
[TBL] [Abstract] [Full Text] [Related]
4. Effects of Regional and General Anesthesia on the Therapeutic Outcome of Benign Thyroid Nodules Treated with High Intensity Focused Ultrasound (HIFU).
Vorländer C; Fischer A; Korkusuz H
World J Surg; 2022 May; 46(5):1076-1081. PubMed ID: 35072745
[TBL] [Abstract] [Full Text] [Related]
5. Hsa_circ_0000069 Knockdown Inhibits Tumorigenesis and Exosomes with Downregulated hsa_circ_0000069 Suppress Malignant Transformation via Inhibition of stil in Pancreatic cancer.
Ye Z; Zhu Z; Xie J; Feng Z; Li Y; Xu X; Li W; Chen W
Int J Nanomedicine; 2020; 15():9859-9873. PubMed ID: 33324055
[TBL] [Abstract] [Full Text] [Related]
6. Multisite Tumor Sampling Reveals Extensive Heterogeneity of Tumor and Host Immune Response in Ovarian cancer.
Lakis S; Kotoula V; Koliou GA; Efstratiou I; Chrisafi S; Papanikolaou A; Zebekakis P; Fountzilas G
Cancer Genomics Proteomics; 2020; 17(5):529-541. PubMed ID: 32859631
[TBL] [Abstract] [Full Text] [Related]
7. [Spontaneous Tumor Lysis Syndrome in a Patient with Testicular Malignant Lymphoma : A Case Report].
Ichikawa K; Momose H; Mizobuchi SI; Itami Y; Nakahama T; Matsumoto Y; Nakamura T
Hinyokika Kiyo; 2019 Feb; 65(2):49-53. PubMed ID: 31067843
[TBL] [Abstract] [Full Text] [Related]
8. [Metachronous Development of Mantle Cell Lymphoma during Active Surveillance in a Patient with Stage I Testicular cancer].
Sano K; Kimura T; Kawai K; Ikeda A; Ishitsuka R; Kandori S; Waku N; Hoshi A; Kojima T; Joraku A; Hashimoto R; Nishiyama H
Hinyokika Kiyo; 2018 Dec; 64(12):509-513. PubMed ID: 30831668
[TBL] [Abstract] [Full Text] [Related]
9. Interleukin‑6 induces an epithelial‑mesenchymal transition phenotype in human adamantinomatous craniopharyngioma cells and promotes tumor cell migration.
Zhou J; Zhang C; Pan J; Chen L; Qi ST
Mol Med Rep; 2017 Jun; 15(6):4123-4131. PubMed ID: 28487953
[TBL] [Abstract] [Full Text] [Related]
10. Targeting the centriolar replication factor stil synergizes with DNA damaging agents for treatment of ovarian cancer.
Rabinowicz N; Mangala LS; Brown KR; Checa-Rodriguez C; Castiel A; Moskovich O; Zarfati G; Trakhtenbrot L; Levy-Barda A; Jiang D; Rodriguez-Aguayo C; Pradeep S; van Praag Y; Lopez-Berestein G; David A; Novikov I; Huertas P; Rottapel R; Sood AK; Izraeli S
Oncotarget; 2017 Apr; 8(16):27380-27392. PubMed ID: 28423708
[TBL] [Abstract] [Full Text] [Related]
11. A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-α2b in patients with recurrent epithelial ovarian cancer.
Dijkgraaf EM; Santegoets SJ; Reyners AK; Goedemans R; Wouters MC; Kenter GG; van Erkel AR; van Poelgeest MI; Nijman HW; van der Hoeven JJ; Welters MJ; van der Burg SH; Kroep JR
Ann Oncol; 2015 Oct; 26(10):2141-9. PubMed ID: 26216383
[TBL] [Abstract] [Full Text] [Related]
12. The silencing of N-myc downstream-regulated gene-1 in an orthotopic pancreatic cancer model leads to more aggressive tumor growth and metastases.
Kim-Fuchs C; Winterhalder S; Winter A; Malinka T; Born D; Schäfer S; Stroka D; Gloor B; Candinas D; Angst E
Dig Surg; 2014; 31(2):135-42. PubMed ID: 24970329
[TBL] [Abstract] [Full Text] [Related]
13. Mesothelin overexpression promotes autocrine IL-6/sil-6R trans-signaling to stimulate pancreatic cancer cell proliferation.
Bharadwaj U; Marin-Muller C; Li M; Chen C; Yao Q
Carcinogenesis; 2011 Jul; 32(7):1013-24. PubMed ID: 21515913
[TBL] [Abstract] [Full Text] [Related]
14. [A case of nasal NK/T cell lymphoma presenting with bilateral giant adrenal tumors].
Toba A; Tamura Y; Osajima Y; Kinbara Y; Sato M; Yamaga R; Hashimoto R; Mori S; Miyakoshi S; Ota M; Ito H; Araki A
Nihon Ronen Igakkai Zasshi; 2008 Nov; 45(6):660-5. PubMed ID: 19179800
[TBL] [Abstract] [Full Text] [Related]
15. Targeting liposomal chemotherapy via both tumor cell-specific and tumor vasculature-specific ligands potentiates therapeutic efficacy.
Pastorino F; Brignole C; Di Paolo D; Nico B; Pezzolo A; Marimpietri D; Pagnan G; Piccardi F; Cilli M; Longhi R; Ribatti D; Corti A; Allen TM; Ponzoni M
Cancer Res; 2006 Oct; 66(20):10073-82. PubMed ID: 17047071
[TBL] [Abstract] [Full Text] [Related]
16. The effects of thyroid hormones on circulating markers of cell-mediated immune response, as studied in patients with differentiated thyroid carcinoma before and during thyroxine withdrawal.
Botella-Carretero JI; Prados A; Manzano L; Montero MT; Escribano L; Sancho J; Escobar-Morreale HF
Eur J Endocrinol; 2005 Aug; 153(2):223-30. PubMed ID: 16061828
[TBL] [Abstract] [Full Text] [Related]
17. Immunomodulatory effects of IL-12 in relation to the pineal endocrine function in metastatic cancer patients.
Lissoni P; Rovelli F; Giani L; Fumagalli L; Mandalà M
Nat Immun; 1998; 16(5-6):178-84. PubMed ID: 11061586
[TBL] [Abstract] [Full Text] [Related]
18. Clinical implication of serum sil-2R levels in ovarian cancer.
Wang S; Cai G; Lu Y
J Tongji Med Univ; 1998; 18(2):126-8. PubMed ID: 10806842
[TBL] [Abstract] [Full Text] [Related]
19. Lentinan potentiates immunity and prolongs the survival time of some patients.
Matsuoka H; Seo Y; Wakasugi H; Saito T; Tomoda H
Anticancer Res; 1997; 17(4A):2751-5. PubMed ID: 9252710
[TBL] [Abstract] [Full Text] [Related]
20. Immunopharmacology and cytokine production of a low-dose schedule of intraperitoneally administered human recombinant interleukin-2 in patients with advanced epithelial ovarian carcinoma.
Freedman RS; Gibbons JA; Giedlin M; Kudelka AP; Kavanagh JJ; Edwards CL; Carrasco CH; Nash MA; Platsoucas CD
J Immunother Emphasis Tumor Immunol; 1996 Nov; 19(6):443-51. PubMed ID: 9041464
[TBL] [Abstract] [Full Text] [Related]
[Next]
